232 filings
Page 9 of 12
8-K
aj2tc1g
3 Oct 17
ContraVir Pharmaceuticals to Present at The MicroCap Conference 2017
12:00am
8-K
di6fn
11 Sep 17
ContraVir Pharmaceuticals Receives HBV
12:00am
8-K
m4onerd01tdxi 02
3 Aug 17
ContraVir Pharmaceuticals Selected to Present Two Posters on CRV431 at Upcoming AASLD Meeting® 2017
12:00am
8-K
w29t1
9 Jun 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
i6il0 pict961zya3en
26 May 17
Departure of Directors or Certain Officers
12:00am
8-K
wx3ong yw
4 May 17
Other Events
12:00am
8-K
2i3zi
2 May 17
Contravir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Warrants
12:00am
8-K
evc0g6ajz1b6prrbic
25 Apr 17
ContraVir Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
12:00am
8-K
fz6k1pacvomp
24 Apr 17
Data Enhances Understanding of ContraVir’s Complementary Anti-HBV
12:00am
8-K
5kvbwwimj xo3n2i
20 Apr 17
Oral Presentation at EASL Highlights ContraVir’s Tenofovir Exalidex (TXL™) Antiviral Activity in Hepatitis B (HBV) Patients
12:00am
8-K
d72qarexz ac
4 Apr 17
Other Events
12:00am
8-K
yamq9fjvp520xhbwb0
4 Jan 17
ContraVir Pharmaceuticals to Present at Biotech Showcase 2017
12:00am
8-K
2lzyw2l
3 Jan 17
ContraVir Awarded Grant from Canada’s National Research Council to Advance CRV431 for the Treatment of Hepatitis B
12:00am
8-K
u5qjwu0a0wdopw2s3p
19 Dec 16
Other Events
12:00am
8-K
bp6e6gq94dgsleo
15 Dec 16
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
12:00am
8-K
ovsiy616nu50lwov
9 Dec 16
Other Events
12:00am
8-K
xij0qcbq0b0o fdupr4
7 Nov 16
ContraVir to Present at AASLD’s The Liver Meeting® 2016
12:00am
8-K
5oje5br2mwfzvp6a
13 Oct 16
Study Achieves Proof of Concept for CMX157 in HBV Patients with Favorable Therapeutic Profile
12:00am
8-K
nm4ny34ms0g byq
3 Oct 16
ContraVir to Present at the 15th Annual BIO Investor Forum
12:00am
8-K
dpxaq0os
29 Sep 16
ContraVir to Receive $1.8 Million Through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
12:00am